Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Gritstone Oncology Inc | 4 | 9 | 0 | 7 | €0.54 | €0.50 | -6.977% |
| Cara Therapeutics Inc. | 11 | 6 | 0 | 5 | €0.25 | €4.61 | 1719.510% |
| Trevena Inc. | 3 | 19 | 1 | 4 | €0.15 | €4.60 | 3027.551% |
| Glycomimetics Inc. | 5 | 3 | 0 | 3 | €0.25 | €7.35 | 2870.343% |
| Minerva Neurosciences Inc. | 0 | 7 | 0 | 2 | €2.88 | - | - |
| Owens & Minor Inc. | 2 | 2 | 0 | 1 | €12.10 | €25.05 | 107.032% |
| Sangamo Therapeutics Inc. | 12 | 13 | 0 | 1 | €0.30 | €3.63 | 1113.373% |
| Akebia Therapeutics Inc. | 7 | 3 | 0 | 1 | €0.87 | €3.60 | 312.741% |
| Ardelyx Inc. | 2 | 1 | 1 | 1 | €4.88 | €11.00 | 125.225% |
| Ani Pharmaceuticals Inc. | 3 | 1 | 3 | 1 | €56.50 | €67.50 | 19.469% |
| Ocuphire Pharma Inc. | 6 | 1 | 0 | 0 | €1.41 | €18.37 | 1206.259% |
| T2 Biosystems Inc. | 0 | 7 | 0 | 0 | €0.16 | - | - |
| Fate Therapeutics Inc. | 3 | 3 | 1 | 0 | €2.91 | €7.31 | 151.216% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.22 | - | - |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.93 | - | - |
| Intellia Therapeutics Inc | 17 | 1 | 3 | 0 | €20.98 | €60.53 | 188.534% |
| Avinger Inc. | 2 | 4 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Pacific Biosciences of California Inc. | 9 | 5 | 0 | 0 | €1.20 | €9.62 | 699.327% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Nevro Corp. | 3 | 2 | 0 | 0 | €7.70 | €25.71 | 233.953% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 1 | 0 | ? | €32.00 | 72.367% |
| Cytomx Therapeutics Inc | 2 | 1 | 1 | 0 | €1.20 | €50.00 | 4052.824% |
| Anavex Life Sciences Corp | 1 | 2 | 1 | 0 | €3.86 | €5.50 | 42.450% |
| Agenus Inc. | 5 | 2 | 2 | 0 | €0.41 | €36.85 | 8804.785% |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €0.82 | - | - |